What is the main business of Bbrain?

The main business activity of Bbrain focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 29, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Jana Kilińskiego 55, 05-530 Góra Kalwaria.

Who is on the management board?

The management board consists of: Beata Wioletta Król (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of USD 2,432,189, representing an increase of 21.4% compared to 2024.

Yes, the company recorded a net profit of USD 146,917 in 2025, meaning the company increased its profit by 271.9%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to USD 2,184,516 in 2025, representing 97% of all operating expenses.

Bbrainsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-06-29

Share capital

5 000,00 PLN

Registered address

ul. Jana Kilińskiego 55, 05-530 Góra Kalwaria, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 80 days early.

202527/04/2026
202427/03/2025
202314/03/2024
202206/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 2.43mMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 146.92kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 2.26mMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 299.97kMedianUSD 609.79kAverageUSD 11.85m

Industry

Wholesale of pharmaceutical goods (46.46.Z)Primary

Authorized Representatives

Beata Wioletta Król – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Beata Wioletta Królage 47	91	$1,229.07	91%
Others	9	$121.56	9%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-08-01.

Bank Pekao SA
02 1240 6351 1978 0011 4512 5564
Bank Pekao SA
94 1240 6351 1111 0011 4512 5548

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Medimsp. z o.o.	$4,709,409.19	medim.pl
Technetsasp. z o.o.	$2,651,206.03	technetsa.pl
Medix Sławomir Szwedsp. k.	$2,710,269.66	medix.com.pl
GWS Polandsp. z o.o.	$2,706,990.11	gwspoland.pl
Guerbet Polandsp. z o.o.	$2,512,394.54	guerbet.com
Neoset Profisp. z o.o.	$2,502,244.52	neoset.com.pl
Petronafsp. z o.o.	$2,499,010.09	petronaf.com
Whitemedsp. z o.o.	$2,483,298.97	whitemed.pl
Besins Healthcare Polandsp. z o.o.	$2,176,494.65	besins-healthcare.pl
Eumedsp. z o.o.	$2,086,044.24	eumed.pl